share_log
Reuters ·  Apr 9 11:29
Reviva Pharmaceuticals Holdings Inc : Benchmark Cuts Target Price to $14 From $17
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 370
Write a comment